CN100553673C - The Chinese patent medicine of treatment chronic pharyngitis - Google Patents
The Chinese patent medicine of treatment chronic pharyngitis Download PDFInfo
- Publication number
- CN100553673C CN100553673C CNB2007100538090A CN200710053809A CN100553673C CN 100553673 C CN100553673 C CN 100553673C CN B2007100538090 A CNB2007100538090 A CN B2007100538090A CN 200710053809 A CN200710053809 A CN 200710053809A CN 100553673 C CN100553673 C CN 100553673C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese patent
- patent medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a kind of Chinese patent medicine, particularly relate to a kind of Chinese patent medicine for the treatment of chronic pharyngitis, esophagitis and esophageal carcinoma.Represent that with weight portion Chinese patent medicine contains 20～40 parts of former medicine Radix Angelicae Sinensis, 15～30 parts in the Radix Rehmanniae, 15～30 parts of the Radix Paeoniae Albas, 5～15 parts of CHENXIANG, 20～40 parts of the Radix Aucklandiae, 15～30 parts of Rhizoma Cyperis, 15～30 parts of Radix Curcumaes, 20～40 parts of Pericarpium Citri Reticulataes, 10～30 parts of Radix Peucedanis.This Chinese patent medicine can be made into capsule, also can be made into pill, tablet or powder.Prove that through clinical practice this medicine can effectively be treated chronic pharyngitis, esophagitis and esophageal carcinoma, treating both the principal and secondary aspects of a disease, and efficacy consolidation do not rebound after the healing, and the effective percentage of chronic pharyngitis is reached 90.9%, and cure rate reaches 81.4%; Effective percentage to esophagitis and esophageal carcinoma reaches 89.5%, and cure rate reaches 53.9%.This medical instrument has that instant effect, patient's misery are little, cost is low, product safety, advantage such as without any side effects, is easily accepted by the patient.
Description
One, technical field:
The present invention relates to a kind of Chinese patent medicine, particularly relate to a kind of Chinese patent medicine for the treatment of chronic pharyngitis, esophagitis and esophageal carcinoma.
Two, background technology:
Chronic pharyngitis is a kind of commonly encountered diseases, frequently-occurring disease, is pharyngeal mucosa, tela submucosa and adenoid diffuse inflammation.Its course of disease is long, and the symptom stubbornness is difficult for curing, and gives patient's spirit and animally causes very big misery.Motherland's medical science thinks that this disease is a hyperactivity of fire caused by deficiency of YIN, disturbs on the asthenic fire, so that due to throat lose to support.Its clinical symptoms: pharyngeal discomfort, foreign body sensation, pharyngeal dryness, feel nervous, itch, scorching hot, hypodynia etc., esophagus is smooth, beat the difficulty of choking with sobs down, dry and astringent, the red tongue of defecating, pulse condition stringy and thready pulse.At present in the Chinese patent medicine LIUSHEN WAN and pills for throat disease are arranged, though effective in cure to pharyngitis, chronic pharyngitis, effect is undesirable.JIANMIN YINHOU PIAN, Herba Pileae Scriptae Tabellae on sale turns to medicining mode to contain on the market recently, the treatment pharyngitis is had certain effect, but its prescription is different fully with the present invention.
The esophagitis symptom mainly is in the majority to swallow pain, difficulty, pyrosis and retrosternal pain.When esophagitis is serious, can cause esohagismus and esophageal stricture.When the inflammation of esophagus lower end caused mucosal degeneration to grow the columnar epithelial cell of stomach then, very likely causing was esophageal carcinoma, must be noted that to follow the trail of its variation.Esophageal carcinoma is one of modal malignant tumor, and it takes place normal relevant with factors such as diet, smoking, excessive drinking and esophagus chronic inflammatory disease, heredity, increases with the age growth sickness rate more than 30 years old.Clinical manifestation is in the esophagus foreign body sensation to be arranged, and choking feeling is arranged in the esophagus during feed.Chinese medicine early has understanding to the treatment cancer, with the history in existing more than 1,000 year of treatment by Chinese herbs tumor, and has accumulated a large amount of square medicines.Chinese and Western medicine has been compared many different characteristics, and the antitumaous effect of Western medicine is very fast, but toxic and side effects is big; The antitumaous effect of the traditional Chinese medical science is slow, but efficacy consolidation, toxic and side effects is little, is easily accepted by the patient.
Granted publication number for the patent disclosure of CN1069200C a kind of Chinese patent medicine for the treatment of chronic pharyngitis, but the production cycle of this medicine is longer, needs pickle 80-100 days, cure rate is also not as the present invention; Granted publication is number for the patent of CN1141131C also discloses a kind of Chinese patent medicine for the treatment of chronic pharyngitis, but its raw material and difference of the present invention are bigger; Granted publication number for the patent disclosure of CN1197608C a kind of Chinese patent medicine for the treatment of esophageal carcinoma, its raw material and difference of the present invention are bigger, cure rate is also lower.
Three, summary of the invention:
The object of the invention: develop a kind of Chinese patent medicine that can effectively treat chronic pharyngitis, esophagitis and esophageal carcinoma.
Technical scheme of the present invention:
A kind of Chinese patent medicine for the treatment of chronic pharyngitis, represent with weight portion, contain 20～40 parts of former medicine Radix Angelicae Sinensis, 15～30 parts in the Radix Rehmanniae, 15～30 parts of the Radix Paeoniae Albas, 5～15 parts of Lignum Aquilariae Resinatum, 20～40 parts of the Radix Aucklandiae, 15～30 parts of Rhizoma Cyperis, 15～30 parts of Radix Curcumaes, 20～40 parts of Pericarpium Citri Reticulataes, 10～30 parts of Radix Peucedanis;
Be preferably: 25～35 parts of Radix Angelicae Sinensis, 20～25 parts in the Radix Rehmanniae, 20～25 parts of the Radix Paeoniae Albas, 8～12 parts of Lignum Aquilariae Resinatum, 25～35 parts of the Radix Aucklandiae, 20～25 parts of Rhizoma Cyperis, 20～25 parts of Radix Curcumaes, 25～35 parts of Pericarpium Citri Reticulataes, 15～25 parts of Radix Peucedanis;
Also contain 5～15 parts of former medicine Haematitums in the described Chinese patent medicine.
A kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, represent with weight portion, contain 20～40 parts of former medicine Radix Angelicae Sinensis, 15～30 parts in the Radix Rehmanniae, 15～30 parts of the Radix Paeoniae Albas, 5～15 parts of Lignum Aquilariae Resinatum, 20～40 parts of the Radix Aucklandiae, 15～30 parts of Rhizoma Cyperis, 15～30 parts of Radix Curcumaes, 20～40 parts of Pericarpium Citri Reticulataes, 10～30 parts of Radix Peucedanis, 20～40 parts of Endothelium Corneum Gigeriae Galli, each 10～20 parts of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata);
Be preferably: 25～35 parts of Radix Angelicae Sinensis, 20～25 parts in the Radix Rehmanniae, 20～25 parts of the Radix Paeoniae Albas, 8～12 parts of Lignum Aquilariae Resinatum, 25～35 parts of the Radix Aucklandiae, 20～25 parts of Rhizoma Cyperis, 20～25 parts of Radix Curcumaes, 25～35 parts of Pericarpium Citri Reticulataes, 15～25 parts of Radix Peucedanis, 25～35 parts of Endothelium Corneum Gigeriae Galli, each 13～17 parts of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata);
Also contain 10～20 parts of former medicine Cortex Magnoliae Officinalis, 5～15 parts of Haematitums in the Chinese patent medicine of described treatment esophagitis and esophageal carcinoma;
Also contain 10～20 parts on former medicine Flos Carthami, 5～15 parts of Fructus Foeniculi in the Chinese patent medicine of described treatment esophagitis and esophageal carcinoma.
Treatment chronic pharyngitis of the present invention, esophagitis and esophageal carcinoma Chinese patent medicine can be made into capsule, or are pill, or are tablet, or are powder.
Described capsule, pill, tablet or powder are that pharmaceutical methods is prepared from routinely.
Consumption and usage when Chinese patent medicine of the present invention is made capsule: oral, every day three times, taking medicine before meal is used.Be grown up each 6, the child is by one of the each clothes of every 15kg body weight.
Chinese patent medicine of the present invention also routinely medicine making method make pill, powder or tablet, consumption is with reference to capsule.
Chinese patent medicine pharmacology analysis of the present invention:
Theory of Chinese medical science thinks that Radix Angelicae Sinensis can be enriched blood and be invigorated blood circulation, and menstruction regulating and pain relieving is moisturized, and laxation has antiinflammatory, antitumaous effect, can be widely used in various tumors; The Radix Rehmanniae, cool in nature, sweet in the mouth is gone into the heart, liver, kidney channel, can removing heat from blood, again can YIN nourishing, the effect of tool heat clearing away YIN nourishing, cooling blood for hemostasis, promoting the production of body fluid to quench thirst; The Radix Paeoniae Alba, the property hardship, acid is slightly cold, and returns liver, spleen channel, cures mainly the suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating; Lignum Aquilariae Resinatum, the property hardship, temperature is gone into kidney, spleen, stomach warp, but the sending down the abnormal ascending QI warming middle-JIAO, the warming the kidney improving inspiration by invigorating kidney-QI; But Radix Aucklandiae promoting the circulation of QI to relieve pain, Lignum Aquilariae Resinatum are joined the Radix Aucklandiae and are had and regulate the flow of vital energy, circulation of qi promoting, fall gastric qi and QI stored in the thorax;
Rhizoma Cyperi and Radix Curcumae all can dispersing the stagnated live-QI to relieve the stagnation of QI, promoting blood flow to regulate menstruation, Chang Peiwu clinically, and Rhizoma Cyperi property of medicine temperature partially, and the power of pain relieving is preferable; Radix Curcumae, property is cold and cool partially, the power of pain relieving is more slow, and can reduce phlegm wet, removing heat from blood is warm, promoting the function of the gallbladder to alleviate jaundice, can invigorate blood circulation, the gas in the promoting the circulation of blood, treating blood disorders, makes normal circulation of qi and blood, the gas not stasis of blood of blood that do not stagnate; Pericarpium Citri Reticulatae, property suffering, hardship, temperature are included into lung, spleen channel, energy circulation of qi promoting spleen invigorating, drying dampness to eliminate phlegm; Radix Peucedani, cold in nature, the bitter in the mouth suffering is gone into lung, spleen channel, the wind heat clearing away of loosing, lowering the adverse-rising QI to resolve phlegm; Endothelium Corneum Gigeriae Galli, sweet, flat, go into spleen, stomach warp, removing food stagnancy stagnates, and strengthening the spleen and stomach is joined Radix Angelicae Sinensis, the Radix Paeoniae Alba, during circulation of qi promoting is strong, enrich blood and stimulate the menstrual flow;
JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), i.e. Fructus Hordei Germinatus (parched to brown), Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown) often share three medicines clinically and are called " JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) ", are the good medicine of dyspepsia and intestinal stasis relieving, invigorating the spleen and stomach; Flos Carthami is the flower of dicotyledon medicine feverfew Flos Carthami, energy promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving; Cortex Magnoliae Officinalis, another name CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China, Cortex Magnoliae Officinalis, property hardship, suffering, temperature are returned spleen, stomach, lung, large intestine channel, energy promoting the circulation of QI to remove dampness, lowering the adverse QI to relieve asthma; Fructus Foeniculi, property suffering, temperature, the pain relieving of energy cold relieving, regulating qi-flowing for harmonizing stomach; Haematitum is Haematitum again, and the property hardship is cold, returns liver, heart channel, energy suppressing the hyperactive liver and subsiding YANG, stomach function regulating sending down the abnormal ascending QI, cooling blood for hemostasis; Fructus Aurantii Immaturus, is slightly cold at bitter in the mouth, returns spleen, stomach, large intestine channel, can circulation of qi promoting remove distension, the numbness of reducing phlegm out, consumer product dredge stasis.
Radix Angelicae Sinensis, Lignum Aquilariae Resinatum are monarch drug in above raw material, and the Radix Rehmanniae, the Radix Paeoniae Alba, the Radix Aucklandiae, Rhizoma Cyperi, Radix Curcumae are ministerial drug.
The positive beneficial effect of Chinese patent medicine of the present invention:
(1) Chinese patent medicine of the present invention is according to the traditional theory of the traditional Chinese medical science, by the four generation traditional Chinese medical science larynx old and well-known families' of section secret prescription handed down in the family from generation to generation, through several generations' explorations of concentrating on studies, test for many years, again through for many years clinical experiment with improve just to screen and sum up out.This Chinese medicine preparation is reasonable, has effects such as the promoting the circulation of blood of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling, spleen benefiting and stimulating the appetite, cough-relieving preventing or arresting vomiting are reduced phlegm, lowering the adverse flow of QI.Prove that through clinical practice this medicine can effectively be treated chronic pharyngitis, esophagitis and esophageal carcinoma, treating both the principal and secondary aspects of a disease, and efficacy consolidation do not rebound after the healing.Effective percentage to chronic pharyngitis reaches 90.9%, and cure rate reaches 81.4%; Effective percentage to esophagitis and esophageal carcinoma reaches 89.5%, and cure rate reaches 53.9%.
(2) the present invention is pure tcm product, has instant effect, the patient suffering is little, cost is low, safe, not drug resistance, advantage such as without any side effects, is easily accepted by the patient.
(3) this product of the present invention special effect aspect treatment chronic pharyngitis, esophagitis and esophageal carcinoma, from various parts of the country through the case of curing for many years, have thousands of, cured a collection of for many years ill and, alleviated the patient suffering greatly even saved patient's life with Western medicine, the cureless patient of Chinese medicine.This medicine reacts in the patient well, firmly gets patient's favorable comment.
Only enumerate some concrete case explanations in recent years below:
1. Feng, the woman, 59 years old, be the worker of Zhengzhou insecticide factory, suffer from chronic pharyngitis more than ten years, often there is foreign body sensation the throat, and pain is beaten the difficulty of choking with sobs down, stool is dry and astringent, sees the doctor for treatment poor effect everywhere.Find the inventor in October, 2003 under the situation of being driven into a corner, according to dosage take for the patient with the Chinese patent medicine of embodiment three, every day three times, each six, 15 days is a course of treatment.In succession take four courses of treatment after, go examination in hospital to heal entirely, not recurrence so far, curative effect is better.
2. swim certain, the man, 41 years old, the Zheng civilian worker that comes for Xinyang, Henan began to feel pharyngeal discomfort, and foreign body sensation is arranged, pharyngeal dryness, scorching hot, hypodynia etc. go examination in hospital to be diagnosed as chronic pharyngitis.In May, 2004, the patient found the inventor, began according to dosage to take to the patient with the Chinese patent medicine of embodiment five, and every day three times, each six, 15 days is a course of treatment.After only taking a course of treatment, go examination in hospital to heal entirely again.
3. Wu, the man, 30 years old, the cook in one tame restaurant, Zhengzhou City suffered from chronic pharyngitis more than 5 years, and with western medicine for several times, symptom does not have and is clearly better.Again with plurality of Chinese treatments such as antiinflammatory lozenge, LIUSHEN WAN, ice Moschus moschiferous loose, symptom does not have yet and is clearly better, and the patient has lost the confidence of curing.In August, 2005, the patient found the inventor upon somebody's introduction, began according to dosage to take to the patient with the Chinese patent medicine of embodiment six, and 15 days is a course of treatment, only just healed entirely three courses of treatment.
4. Lu, the woman, 41 years old, the pipe city cadre of Zhengzhou City suffered from chronic pharyngitis more than 6 years, and once how tame large hospital is treated in the Zhengzhou City, and Western medicine, Chinese medicine were all used, and symptom does not have and is clearly better.In October, 2005 patient upon somebody's introduction, have the idea of trying in arms and find the inventor, begin according to dosage to take to the patient with the Chinese patent medicine of embodiment eight, 15 days is a course of treatment.Only take and just heal entirely three courses of treatment.So far not recurrence, curative effect is better.The patient is very grateful, has introduced a lot of other pharyngitis patients to the inventor afterwards, and large quantities of patients have cured, and therefore this medicine wins vast pharyngitis patient's trust.
5. Zheng, the woman, 39 years old, come Zhengzhou to make business for many years, people from Hanzhong suffers from surplus the chronic pharyngitis ten year, in the treatment of Zhengzhou Duo Jia large hospital, do not obtain radical cure, and symptom does not have and is clearly better.In March, 2005, the patient found the inventor out of admiration for a famous person, check to find the hyperemia of patient's pharyngeal mucous membrane, have mucus to adhere to, to swallow rear wall red, and lymph follicle is arranged, begin according to dosage to take to the patient with the Chinese patent medicine of embodiment eight, 15 days is a course of treatment, and the medicine of only taking 4～5 courses of treatment is just healed entirely.So far not recurrence, curative effect is better.
The side certain, the woman, 73 years old, be people from Zhengzhou City, suffer from chronic pharyngitis more than 7 years, in Zhengzhou and all parts of the country seek medical advice and have no result, symptom does not have and is clearly better.In March, 2004, the patient found the inventor, began according to dosage to take to the patient with the Chinese patent medicine of embodiment seven, and 15 days is a course of treatment, only with just healing entirely 5 courses of treatment.So far not recurrence, curative effect is better.
7. Zhang, man, 73 years old, people from Tongxu County, Henan Province.Nineteen ninety-five December, the patient makes a definite diagnosis through examination in hospital and has suffered from the esophageal carcinoma in mid-term, many half a year in Kaifeng one tame large hospital treatment, symptom does not take a turn for the better.The patient finds the inventor in October, 1996, begins according to dosage to take to the patient with the Chinese patent medicine of embodiment 13, and 20 days is a course of treatment, in succession take six courses of treatment after, go the examination in hospital to heal entirely again, 10 years so far, the patient is still alive, can also go to work in the fields.
8. Jin, woman, 59 years old, people from Zhengzhou City.Suffer from esophagitis more than 2 years, find the inventor to treat in March, 2006, begins according to dosage to take to the patient with the Chinese patent medicine of embodiment 18, and 20 days is a course of treatment, in succession take four courses of treatment after, go examination in hospital to heal entirely again.
9. Lee, woman, 74 years old, people from Zhengzhou City.In February, 2004, the patient makes a definite diagnosis through examination in hospital and has suffered from advanced esophageal cancer, and one tame section hospital fails to respond to any medical treatment in Zhengzhou, and hospital has given the notice of being critically ill.Under the situation of being driven into a corner, it is all difficult to find the inventor, patient to drink water at that time in November, 2004, and health is become thin, and general weakness is nervous, feeble in a minute, lethargy.Begin according to dosage to take to the patient with the Chinese patent medicine of embodiment 24,20 days is a course of treatment, take 3 courses of treatment after, begin and can drink water, can eat mashed noodles, spirit takes a turn for the better to some extent.In succession take 3 courses of treatment again after, patient's appetite is the same with the normal person, health begins to get fat, and has rosy cheeks, and goes examination in hospital to find that esophageal carcinoma heals entirely.
10. chronic pharyngitis, esophagitis and esophageal carcinoma result on trial are added up:
Timing statistics: in November, 2002～2006 year November
Among the 296 routine patients, women's 165 examples, male's 131 examples, the age, the patient had chronic pharyngitis, esophagitis and esophageal carcinoma all more than 30 years old, wherein chronic pharyngitis patient 220 examples, esophagitis and esophageal carcinoma patient 76 examples.Through taking Chinese patent medicine of the present invention, effect obviously has 200 people with the chronic pharyngitis patient who cures among the chronic pharyngitis patient, and effective percentage reaches 90.9%; Wherein have 179 people complete through treating, cure rate reaches 81.4%.
Among 76 routine esophagitis and the esophageal carcinoma patient, through taking Chinese patent medicine of the present invention, effect obviously has 68 people with the patient who cures, and effective percentage reaches 89.5%; Wherein have 41 people complete through treating, cure rate reaches 53.9%.
The patient must not take other drug at period in a medicine.The control that is careful in one's diet, diet is peppery, cool, living, cold etc. stimulates based food, give up tobacco and wine.Chinese patent medicine of the present invention does not have any untoward reaction to most patients, slight diarrhoea and dizzy can occur after the individual patient medication, and symptom promptly disappears after the drug withdrawal.
Four, the specific embodiment:
Embodiment one: a kind of Chinese patent medicine for the treatment of chronic pharyngitis, represent with weight portion, former medicine Radix Angelicae Sinensis 20kg, Radix Rehmanniae 15kg, Radix Paeoniae Alba 15kg, Lignum Aquilariae Resinatum 5kg, Radix Aucklandiae 20kg, Rhizoma Cyperi 15kg, Radix Curcumae 15kg, Pericarpium Citri Reticulatae 20kg, Radix Peucedani 10kg, each component is ground into 120 order powder respectively, mix homogeneously, capsule is made in sterilization, packing, every 0.5 gram.
Embodiment two: a kind of Chinese patent medicine for the treatment of chronic pharyngitis, represent with weight portion, former medicine Radix Angelicae Sinensis 4kg, Radix Rehmanniae 3kg, Radix Paeoniae Alba 3kg, Lignum Aquilariae Resinatum 1.5kg, Radix Aucklandiae 4kg, Rhizoma Cyperi 3kg, Radix Curcumae 3kg, Pericarpium Citri Reticulatae 4kg, Radix Peucedani 3kg, each component is ground into 150 order powder respectively, mix homogeneously, sterilization, packing, pharmaceutical methods is made tablet routinely, or make pill, or make powder.
Embodiment three: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 2.2kg, Radix Rehmanniae 1.7kg, Radix Paeoniae Alba 2.8kg, Lignum Aquilariae Resinatum 1.3kg, Radix Aucklandiae 3.8kg, Rhizoma Cyperi 1.7kg, Radix Curcumae 1.7kg, Pericarpium Citri Reticulatae 3.8kg, Radix Peucedani 2.8kg.
Embodiment four: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 38kg, Radix Rehmanniae 28kg, Radix Paeoniae Alba 17kg, Lignum Aquilariae Resinatum 7kg, Radix Aucklandiae 22kg, Rhizoma Cyperi 27kg, Radix Curcumae 27kg, Pericarpium Citri Reticulatae 23kg, Radix Peucedani 12kg.
Embodiment five: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 25kg, Radix Rehmanniae 25kg, Radix Paeoniae Alba 22kg, Lignum Aquilariae Resinatum 10kg, Radix Aucklandiae 32kg, Rhizoma Cyperi 23kg, Radix Curcumae 20kg, Pericarpium Citri Reticulatae 25kg, Radix Peucedani 18kg, Haematitum 15kg.
Embodiment six: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 33kg, Radix Rehmanniae 20kg, Radix Paeoniae Alba 18kg, Lignum Aquilariae Resinatum 12kg, Radix Aucklandiae 27kg, Rhizoma Cyperi 20kg, Radix Curcumae 23kg, Pericarpium Citri Reticulatae 30kg, Radix Peucedani 26kg, Haematitum 5kg.
Embodiment seven: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 30kg, Radix Rehmanniae 16kg, Radix Paeoniae Alba 28kg, Lignum Aquilariae Resinatum 13kg, Radix Aucklandiae 21kg, Rhizoma Cyperi 29kg, Radix Curcumae 28kg, Pericarpium Citri Reticulatae 32kg, Radix Peucedani 12kg, Haematitum 12kg.
Embodiment eight: basic identical with embodiment one, difference is:
Former explosive component: Radix Angelicae Sinensis 35kg, Radix Rehmanniae 22kg, Radix Paeoniae Alba 25kg, Lignum Aquilariae Resinatum 14kg, Radix Aucklandiae 38kg, Rhizoma Cyperi 26kg, Radix Curcumae 29kg, Pericarpium Citri Reticulatae 36kg, Radix Peucedani 16kg, Haematitum 8kg.
Embodiment nine: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, former explosive component: Radix Angelicae Sinensis 26kg, Radix Rehmanniae 26kg, Radix Paeoniae Alba 22kg, Lignum Aquilariae Resinatum 6kg, Radix Aucklandiae 29kg, Rhizoma Cyperi 19kg, Radix Curcumae 24kg, Pericarpium Citri Reticulatae 32kg, Radix Peucedani 24kg, Endothelium Corneum Gigeriae Galli 39kg, each 17kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) (being Fructus Hordei Germinatus (parched to brown), Fructus Crataegi (parched to brown), each 17kg of Massa Medicata Fermentata (parched to brown)), Cortex Magnoliae Officinalis 10kg, Haematitum 5kg.Each component is ground into 120 order powder respectively, mix homogeneously, capsule is made in sterilization, packing, every 0.5 gram.
Embodiment ten: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, former explosive component: Radix Angelicae Sinensis 20kg, Radix Rehmanniae 18kg, Radix Paeoniae Alba 15kg, Lignum Aquilariae Resinatum 7kg, Radix Aucklandiae 40kg, Rhizoma Cyperi 15kg, Radix Curcumae 28kg, Pericarpium Citri Reticulatae 40kg, Radix Peucedani 26kg, Endothelium Corneum Gigeriae Galli 36kg, each 19kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 13kg, Haematitum 14kg.Each component is ground into 150 order powder respectively, mixes in proportion, sterilization, pharmaceutical methods is made tablet routinely.
Embodiment 11: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: Radix Angelicae Sinensis 38kg, Radix Rehmanniae 23kg, Radix Paeoniae Alba 22kg, Lignum Aquilariae Resinatum 12kg, Radix Aucklandiae 36kg, Rhizoma Cyperi 13kg, Radix Curcumae 19kg, Pericarpium Citri Reticulatae 20kg, Radix Peucedani 18kg, Endothelium Corneum Gigeriae Galli 26kg, each 12kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 16kg, Haematitum 12kg.
Embodiment 12: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: Radix Angelicae Sinensis 22kg, Radix Rehmanniae 28kg, Radix Paeoniae Alba 30kg, Lignum Aquilariae Resinatum 14kg, Radix Aucklandiae 20kg, Rhizoma Cyperi 25kg, Radix Curcumae 16kg, Pericarpium Citri Reticulatae 22kg, Radix Peucedani 12kg, Endothelium Corneum Gigeriae Galli 22kg, each 15kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 19kg, Haematitum 7kg.
Embodiment 13: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 20 parts of Radix Angelicae Sinensis 25kg, Radix Rehmanniae 25kg, Radix Paeoniae Alba 22kg, Lignum Aquilariae Resinatum 10kg, Radix Aucklandiae 28kg, Rhizoma Cyperi 24kg, Radix Curcumae 22kg, Pericarpium Citri Reticulatae 27kg, Radix Peucedani 19kg, Endothelium Corneum Gigeriae Galli 32kg, each 14kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 14kg, Haematitum 10kg, Fructus Aurantii Immaturuss.
Embodiment 14: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 10 parts of Radix Angelicae Sinensis 32kg, Radix Rehmanniae 20kg, Radix Paeoniae Alba 20kg, Lignum Aquilariae Resinatum 12kg, Radix Aucklandiae 25kg, Rhizoma Cyperi 20kg, Radix Curcumae 20kg, Pericarpium Citri Reticulatae 32kg, Radix Peucedani 23kg, Endothelium Corneum Gigeriae Galli 30kg, each 17kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 16kg, Haematitum 13kg, Fructus Aurantii Immaturuss.
Embodiment 15: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 15 parts of Radix Angelicae Sinensis 26kg, Radix Rehmanniae 22kg, Radix Paeoniae Alba 25kg, Lignum Aquilariae Resinatum 13kg, Radix Aucklandiae 22kg, Rhizoma Cyperi 27kg, Radix Curcumae 24kg, Pericarpium Citri Reticulatae 27kg, Radix Peucedani 19kg, Endothelium Corneum Gigeriae Galli 34kg, each 12kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Cortex Magnoliae Officinalis 13kg, Haematitum 17kg, Fructus Aurantii Immaturuss.
Embodiment 16: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: Radix Angelicae Sinensis 40kg, Radix Rehmanniae 20kg, Radix Paeoniae Alba 22kg, Lignum Aquilariae Resinatum 8kg, Radix Aucklandiae 29kg, Rhizoma Cyperi 19kg, Radix Curcumae 24kg, Pericarpium Citri Reticulatae 32kg, Radix Peucedani 24kg, Endothelium Corneum Gigeriae Galli 39kg, each 17kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 10kg, Fructus Foeniculi 5kg, Cortex Magnoliae Officinalis 10kg, Haematitum 5kg.
Embodiment 17: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 20 parts of Radix Angelicae Sinensis 30kg, Radix Rehmanniae 24kg, Radix Paeoniae Alba 20kg, Lignum Aquilariae Resinatum 14kg, Radix Aucklandiae 30kg, Rhizoma Cyperi 23kg, Radix Curcumae 23kg, Pericarpium Citri Reticulatae 37kg, Radix Peucedani 16kg, Endothelium Corneum Gigeriae Galli 30kg, each 15kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 20kg, Cortex Magnoliae Officinalis 16kg, Fructus Foeniculi 15kg, Haematitum 15kg, Fructus Aurantii Immaturuss.
Embodiment 18: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 10 parts of Radix Angelicae Sinensis 25kg, Radix Rehmanniae 24kg, Radix Paeoniae Alba 26kg, Lignum Aquilariae Resinatum 8kg, Radix Aucklandiae 35kg, Rhizoma Cyperi 24kg, Radix Curcumae 29kg, Pericarpium Citri Reticulatae 27kg, Radix Peucedani 22kg, Endothelium Corneum Gigeriae Galli 24kg, each 11kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 13kg, Cortex Magnoliae Officinalis 18kg, Fructus Foeniculi 7kg, Haematitum 10kg, Fructus Aurantii Immaturuss.
Embodiment 19: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 15 parts of Radix Angelicae Sinensis 37kg, Radix Rehmanniae 28kg, Radix Paeoniae Alba 24kg, Lignum Aquilariae Resinatum 13kg, Radix Aucklandiae 23kg, Rhizoma Cyperi 18kg, Radix Curcumae 20kg, Pericarpium Citri Reticulatae 24kg, Radix Peucedani 16kg, Endothelium Corneum Gigeriae Galli 34kg, each 13kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 16kg, Cortex Magnoliae Officinalis 14kg, Fructus Foeniculi 10kg, Haematitum 12kg, Fructus Aurantii Immaturuss.
Embodiment 20: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: Radix Angelicae Sinensis 23kg, Radix Rehmanniae 18kg, Radix Paeoniae Alba 19kg, Lignum Aquilariae Resinatum 10kg, Radix Aucklandiae 27kg, Rhizoma Cyperi 26kg, Radix Curcumae 24kg, Pericarpium Citri Reticulatae 36kg, Radix Peucedani 29kg, Endothelium Corneum Gigeriae Galli 23kg, each 19kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 18kg, Cortex Magnoliae Officinalis 13kg, Fructus Foeniculi 12kg, Haematitum 14kg.
Embodiment 21: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: Radix Angelicae Sinensis 36kg, Radix Rehmanniae 22kg, Radix Paeoniae Alba 16kg, Lignum Aquilariae Resinatum 9kg, Radix Aucklandiae 25kg, Rhizoma Cyperi 22kg, Radix Curcumae 26kg, Pericarpium Citri Reticulatae 26kg, Radix Peucedani 20kg, Endothelium Corneum Gigeriae Galli 33kg, each 17kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 12kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 14kg, Haematitum 8kg.
Embodiment 22: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 10 parts of Radix Angelicae Sinensis 30kg, Radix Rehmanniae 18kg, Radix Paeoniae Alba 18kg, Lignum Aquilariae Resinatum 10kg, Radix Aucklandiae 20kg, Rhizoma Cyperi 16kg, Radix Curcumae 28kg, Pericarpium Citri Reticulatae 36kg, Radix Peucedani 12kg, Endothelium Corneum Gigeriae Galli 38kg, each 19kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 12kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 13kg, Haematitum 8kg, Fructus Aurantii Immaturuss.
Embodiment 23: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 20 parts of Radix Angelicae Sinensis 32kg, Radix Rehmanniae 20kg, Radix Paeoniae Alba 20kg, Lignum Aquilariae Resinatum 14kg, Radix Aucklandiae 23kg, Rhizoma Cyperi 20kg, Radix Curcumae 25kg, Pericarpium Citri Reticulatae 32kg, Radix Peucedani 15kg, Endothelium Corneum Gigeriae Galli 35kg, each 17kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 14kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 11kg, Haematitum 6kg, Fructus Aurantii Immaturuss.
Embodiment 24: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 12 parts of Radix Angelicae Sinensis 26kg, Radix Rehmanniae 27kg, Radix Paeoniae Alba 23kg, Lignum Aquilariae Resinatum 12kg, Radix Aucklandiae 28kg, Rhizoma Cyperi 26kg, Radix Curcumae 22kg, Pericarpium Citri Reticulatae 30kg, Radix Peucedani 19kg, Endothelium Corneum Gigeriae Galli 31kg, each 15kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 16kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 9kg, Haematitum 10kg, Fructus Aurantii Immaturuss.
Embodiment 25: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 18 parts of Radix Angelicae Sinensis 33kg, Radix Rehmanniae 28kg, Radix Paeoniae Alba 25kg, Lignum Aquilariae Resinatum 9kg, Radix Aucklandiae 31kg, Rhizoma Cyperi 28kg, Radix Curcumae 20kg, Pericarpium Citri Reticulatae 22kg, Radix Peucedani 22kg, Endothelium Corneum Gigeriae Galli 28kg, each 13kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 18kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 7kg, Haematitum 12kg, Fructus Aurantii Immaturuss.
Embodiment 26: a kind of Chinese patent medicine for the treatment of esophagitis and esophageal carcinoma, and basic identical with embodiment nine, difference is:
Former explosive component: 15 parts of Radix Angelicae Sinensis 31kg, Radix Rehmanniae 20kg, Radix Paeoniae Alba 28kg, Lignum Aquilariae Resinatum 6kg, Radix Aucklandiae 35kg, Rhizoma Cyperi 30kg, Radix Curcumae 17kg, Pericarpium Citri Reticulatae 20kg, Radix Peucedani 26kg, Endothelium Corneum Gigeriae Galli 23kg, each 11kg of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Flos Carthami 20kg, Cortex Magnoliae Officinalis 15kg, Fructus Foeniculi 5kg, Haematitum 14kg, Fructus Aurantii Immaturuss.
Claims (5)
1, a kind of Chinese patent medicine for the treatment of chronic pharyngitis, it is characterized in that: represent with weight portion, contain 20～40 parts of former medicine Radix Angelicae Sinensis, 15～30 parts in the Radix Rehmanniae, 15～30 parts of the Radix Paeoniae Albas, 5～15 parts of Lignum Aquilariae Resinatum, 20～40 parts of the Radix Aucklandiae, 15～30 parts of Rhizoma Cyperis, 15～30 parts of Radix Curcumaes, 20～40 parts of Pericarpium Citri Reticulataes, 10～30 parts of Radix Peucedanis.
2, Chinese patent medicine according to claim 1 is characterized in that: 25～35 parts of Radix Angelicae Sinensis, 20～25 parts in the Radix Rehmanniae, 20～25 parts of the Radix Paeoniae Albas, 8～12 parts of Lignum Aquilariae Resinatum, 25～35 parts of the Radix Aucklandiae, 20～25 parts of Rhizoma Cyperis, 20～25 parts of Radix Curcumaes, 25～35 parts of Pericarpium Citri Reticulataes, 15～25 parts of Radix Peucedanis in the former medicine.
3, Chinese patent medicine according to claim 1 and 2 is characterized in that: also contain 5～15 parts of former medicine Haematitums.
4, Chinese patent medicine according to claim 1 and 2 is characterized in that: described Chinese patent medicine is a capsule or for pill or for tablet or for powder.
5, Chinese patent medicine according to claim 4 is characterized in that: described capsule, pill, tablet or powder are that pharmaceutical methods is prepared from routinely.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100538090A CN100553673C (en) | 2007-01-05 | 2007-01-05 | The Chinese patent medicine of treatment chronic pharyngitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100538090A CN100553673C (en) | 2007-01-05 | 2007-01-05 | The Chinese patent medicine of treatment chronic pharyngitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101028488A CN101028488A (en) | 2007-09-05 |
| CN100553673C true CN100553673C (en) | 2009-10-28 |
Family
ID=38714147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100538090A Expired - Fee Related CN100553673C (en) | 2007-01-05 | 2007-01-05 | The Chinese patent medicine of treatment chronic pharyngitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100553673C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101628039B (en) * | 2009-08-19 | 2011-09-28 | 莫聚功 | Traditional Chinese medicine for treating acute and chronic pharyngitis and globus hystericus |
| CN101926963A (en) * | 2010-08-18 | 2010-12-29 | 山西省屯留县科技情报服务中心 | Medicament for treating pharyngitis |
| CN104645102B (en) * | 2015-01-29 | 2015-09-23 | 王林 | A kind of Chinese medicine preparation and preparation method for the treatment of esophagitis |
| CN107308437A (en) * | 2017-06-26 | 2017-11-03 | 郑相国 | Treat and prevent solid beverage of esophagus cancer and preparation method thereof |
-
2007
- 2007-01-05 CN CNB2007100538090A patent/CN100553673C/en not_active Expired - Fee Related
Non-Patent Citations (6)
| Title |
|---|
| 中医中药治疗慢性咽炎近况. 张勉，黄卓燕.河北中医，第25卷第9期. 2003 |
| 中医中药治疗慢性咽炎近况. 张勉，黄卓燕.河北中医，第25卷第9期. 2003 * |
| 咽科学. 陈良盛，李朝仪等.中国医学文摘.耳鼻咽喉科学，第5期. 1990 |
| 咽科学. 陈良盛，李朝仪等.中国医学文摘.耳鼻咽喉科学，第5期. 1990 * |
| 龚振祥治梅核气的经验. 王化京，龚长虹.江西中医药，第26卷第1期. 1995 |
| 龚振祥治梅核气的经验. 王化京，龚长虹.江西中医药，第26卷第1期. 1995 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101028488A (en) | 2007-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102552773B (en) | Drug for treating bronchitis and bronchial asthma of 7-15 year old children | |
| CN103721236B (en) | A kind of Chinese medicine composition for the treatment of gastropathy | |
| CN102058767B (en) | Chinese medicine for treating senile chronic bronchitis and method for preparing pills thereof | |
| CN102526674A (en) | Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
| CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
| CN100553673C (en) | The Chinese patent medicine of treatment chronic pharyngitis | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN103341092A (en) | Preparation method of powder for treating atrophic vaginitis | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN104548029A (en) | Pharmaceutical composition for treating epigastric pain | |
| CN103285203A (en) | Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN103110811B (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN105535636A (en) | Medicinal composition for treating liver-yang hyperactivity type hypertension | |
| CN1387891A (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN103585598B (en) | Chinese medicinal composition for treating chronic colonitis | |
| CN102961662B (en) | Medicine for treating gastric ulcer and preparation method thereof | |
| CN101569708B (en) | Medicament for treating ischemic heart disease and preparation method thereof | |
| CN105998860A (en) | Traditional Chinese medicinal composition for treating osteoarthropathy | |
| CN105125973A (en) | Traditional Chinese medicine preparation for treating infantile bronchitis | |
| CN105079746A (en) | Traditional Chinese medicine for treating rhinitis and preparation method thereof | |
| CN104352773A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091028 Termination date: 20150105 |
|
| EXPY | Termination of patent right or utility model |